UK markets close in 3 hours 47 minutes

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.70-0.67 (-10.52%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,582
1,582
2,512
438.323
386.23
Selling general and administrative
4,692
4,692
5,106
943.039
426.141
Total operating expenses
6,274
6,274
7,618
1,381
812.371
Operating income or loss
-6,274
-6,274
-7,618
-1,381
-812.371
Total other income/expenses net
211.342
211.342
23.215
34.617
-
Income before tax
-6,062
-6,062
-7,595
-1,347
-812.371
Income tax expense
0
0
0
0
0
Income from continuing operations
-6,062
-6,062
-7,595
-1,347
-812.371
Net income
-5,871
-5,871
-7,446
-1,347
-812.371
Net income available to common shareholders
-5,871
-5,871
-7,446
-1,347
-812.371
Basic EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Diluted EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Basic average shares
13,013
13,013
12,806
12,642
12,642
Diluted average shares
13,013
13,013
12,806
12,642
12,642